Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-083627
Filing Date
2024-07-29
Accepted
2024-07-29 18:12:42
Documents
1
Group Members
5AM OPPORTUNITIES I (GP), LLC5AM OPPORTUNITIES I, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABKUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2420416d1_sc13da.htm SC 13D/A 112934
  Complete submission text file 0001104659-24-083627.txt   114735
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Subject) CIK: 0001672619 (see all company filings)

EIN.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91465 | Film No.: 241153856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A